1-4 of 4
Kensaku Sato
Close
Sort by
Journal Articles

In Situ Hybridization of HBZ and Tax in FFPE Samples from ATLL Patients and Its Association with Clinicopathological Characteristics

Kyohei Yamada, MD, Hiroaki Miyoshi, MD PhD, Mai Takeuchi, MD PhD, Naoko Asano, MD PhD, Joji Shimono, MD PhD, Fumiko Arakawa, PhD, Kazutaka Nakashima, Kensaku Sato, PhD, Masao Seto, MD PhD, Koichi Ohshima, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1643.
https://doi.org/10.1182/blood-2018-99-112082
Published: 2018
Journal Articles

Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD

Shoichi Nagakura, Tetsuyuki Kiyokawa, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano
Journal: Blood
Blood (2008) 112 (11): 4315.
https://doi.org/10.1182/blood.V112.11.4315.4315
Published: 2008
Journal Articles

Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning

Tetsuyuki Kiyokawa, Shoichi Nagakura, Michihiro Hidaka, Takahiro Yano, MD, Kazutaka Sunami, MD, PhD, Seiichi Okamura, Naokuni Uike, Motohiro Hamaguchi, Takahiro Matsui, Keizo Horibe, MD, Kensaku Sato, Toshiro Kawakita, Fumio Kawano
Journal: Blood
Blood (2008) 112 (11): 4402.
https://doi.org/10.1182/blood.V112.11.4402.4402
Published: 2008
Journal Articles

Number of Prior Chemotherapy Regimens: Important Prognositic Factor of All-Cause Mortality after Allogeneic Hematopoietic Cell Transplantation.

Tetsuyuki Kiyokawa, MD, Shoichi Nagakura, MD, Michihiro Hidaka, MD, Naokuni Uike, MD, Motohiro Hamaguchi, MD, Keizo Horibe, MD, Kensaku Sato, Humio Kawano, MD
Journal: Blood
Blood (2007) 110 (11): 1104.
https://doi.org/10.1182/blood.V110.11.1104.1104
Published: 2007